OverviewSuggest Edit

I-Mab Biopharma is a biotech company focused on the development of biologics in the therapeutic areas of immuno-oncology and autoimmune diseases. Its research and development capabilities encompass discovery, translational medicine, chemistry, manufacturing and controls (CMC) for biologics, pre-clinical development and clinical development, as well as business development functions. I-Mab Biopharma's pipeline of clinical and pre-clinical stage drug candidates is driven by the Fast-to-PoC (Proof-of-Concept) and Fast-to-Market development strategies through internal R&D capabilities and global partnerships.

TypePublic
Founded2016
HQShanghai, CN
Websitei-mabbiopharma.com

Locations

I-Mab Biopharma is headquartered in
Shanghai, China

Location Map

Latest Updates

Employees (est.) (Sept 2019)176(+32%)
Revenue (FY, 2019)¥30 M(-44%)
Share Price (Jun 2020)$25.8 (+17%)

Key People/Management at I-Mab Biopharma

Jingwu Zang

Jingwu Zang

Founder and Chairman
Joan Huaqiong Shen

Joan Huaqiong Shen

Director and Chief Executive Officer
Zheru Zhang

Zheru Zhang

Director and President
Jielun Zhu

Jielun Zhu

Director and Chief Financial Officer
Lili Qian

Lili Qian

Vice President of Operations
Wei Fu

Wei Fu

Director
Show more

I-Mab Biopharma Office Locations

I-Mab Biopharma has offices in Shanghai, Beijing and Gaithersburg
Shanghai, CN (HQ)
88 Shangke Rd, Pudong Xinqu
Beijing, CN
Da Cheng Da Sha, Xicheng Qu
Gaithersburg, US
9801 Washingtonian Blvd #710
Show all (3)

I-Mab Biopharma Financials and Metrics

I-Mab Biopharma Revenue

I-Mab Biopharma's revenue was reported to be ¥30 m in FY, 2019
CNY

Revenue (FY, 2019)

30.0m

Net income (FY, 2019)

(1.5b)

EBIT (FY, 2019)

(210.4m)

Market capitalization (3-Jun-2020)

1.5b

Closing stock price (3-Jun-2020)

25.8

Cash (31-Dec-2019)

163.4m

EV

1.4b
I-Mab Biopharma's current market capitalization is $1.5 b.
Annual
CNYFY, 2017FY, 2018FY, 2019

Revenue

11.6m53.8m30.0m

Revenue growth, %

365%

General and administrative expense

25.4m66.4m

R&D expense

267.1m426.0m
Half Year
CNYH1, 2018H1, 2019

Revenue

21.4m15.0m

General and administrative expense

18.7m574.6m

R&D expense

202.7m265.1m

Operating expense total

221.4m839.7m
Annual
CNYFY, 2017FY, 2018FY, 2019

Cash

307.9m1.6b163.4m

Prepaid Expenses

19.5m

Current Assets

691.6m2.0b195.5m

PP&E

22.3m27.7m30.1m
Half Year
CNYH1, 2019

Cash

1.3b

Current Assets

1.6b

PP&E

25.1m

Goodwill

162.6m
Annual
CNYFY, 2017FY, 2018FY, 2019

Net Income

(298.2m)(402.8m)(1.5b)

Depreciation and Amortization

1.6m6.7m9.8m

Accounts Payable

188.4m

Cash From Operating Activities

(252.2m)(280.7m)(868.0m)
Half Year
CNYH1, 2018H1, 2019

Net Income

(166.7m)(857.3m)

Depreciation and Amortization

1.4m4.5m

Cash From Operating Activities

(63.7m)(389.0m)

Purchases of PP&E

(4.1m)(1.9m)
CNYY, 2019

EV/EBIT

-6.6 x

EV/CFO

-1.6 x

Revenue/Employee

170.5k

Financial Leverage

-0.9 x
Show all financial metrics

I-Mab Biopharma Operating Metrics

Q3, 2019

Clinical and Pre-Clinical Stage Assets Developed

10

Partners

10

Patents Issued

5

Patents Pending

156
Show all operating metrics

I-Mab Biopharma Acquisitions / Subsidiaries

Company NameDateDeal Size
I-Mab Biopharma Hong Kong Limited
I-Mab Biopharma (Shanghai) Co., Ltd.
I-Mab Biopharma US Ltd.
I-Mab Bio-tech (Tianjin) Co., Ltd.

I-Mab Biopharma Online and Social Media Presence

Embed Graph

I-Mab Biopharma Frequently Asked Questions

  • When was I-Mab Biopharma founded?

    I-Mab Biopharma was founded in 2016.

  • Who are I-Mab Biopharma key executives?

    I-Mab Biopharma's key executives are Jingwu Zang, Joan Huaqiong Shen and Zheru Zhang.

  • How many employees does I-Mab Biopharma have?

    I-Mab Biopharma has 176 employees.

  • What is I-Mab Biopharma revenue?

    Latest I-Mab Biopharma annual revenue is ¥30 m.

  • What is I-Mab Biopharma revenue per employee?

    Latest I-Mab Biopharma revenue per employee is ¥170.5 k.

  • Who are I-Mab Biopharma competitors?

    Competitors of I-Mab Biopharma include ProtoKinetix, Cord Blood America and Magenta Therapeutics.

  • Where is I-Mab Biopharma headquarters?

    I-Mab Biopharma headquarters is located at 88 Shangke Rd, Pudong Xinqu, Shanghai.

  • Where are I-Mab Biopharma offices?

    I-Mab Biopharma has offices in Shanghai, Beijing and Gaithersburg.

  • How many offices does I-Mab Biopharma have?

    I-Mab Biopharma has 3 offices.